Description
Aprezo 10 Tablet contains Apremilast, a phosphodiesterase-4 (PDE4) inhibitor that works by reducing the activity of an enzyme responsible for inflammation in the body. By lowering inflammation, it helps in the management of psoriasis and psoriatic arthritis. Aprezo is considered an advanced oral therapy option, especially for patients who do not respond adequately to conventional treatments.
Uses
-
Treatment of moderate to severe plaque psoriasis
-
Management of psoriatic arthritis (reduces joint pain, swelling, and stiffness)
-
Helps in controlling redness, scaling, and skin irritation caused by psoriasis
Dosage
-
Usually prescribed as part of a dose titration schedule, starting with a lower dose (such as Aprezo 10) and gradually increasing to higher strengths (20mg, 30mg) as per doctor’s advice.
-
Must be taken orally with water, with or without food.
-
Dosage should be strictly followed as prescribed by the physician.
Possible Side Effects
-
Nausea, diarrhea, or stomach upset (common during initial days)
-
Headache
-
Loss of appetite or weight loss (rare)
-
Fatigue or insomnia (in some cases)
-
Mood changes (should be reported immediately to the doctor)
About the Company
Glenmark Pharmaceuticals Ltd is a leading multinational pharmaceutical company with expertise in dermatology, respiratory care, and oncology. Aprezo is one of its innovative medicines in the dermatology segment, providing an effective oral solution for psoriasis and psoriatic arthritis.
Good Things About Aprezo 10 Tablet
-
Advanced oral therapy for psoriasis and psoriatic arthritis
-
Convenient tablet form (no injections required)
-
Helps improve skin appearance and joint mobility
-
Reduces inflammation and disease flare-ups
-
Backed by Glenmark’s expertise in dermatology and specialty medicines
Leave a Reply